{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:29:10Z","timestamp":1793860150163,"version":"4.6.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"publisher","award":["CE69_062_3300_007"],"award-info":[{"award-number":["CE69_062_3300_007"]}],"id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-026-11695-z","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T11:28:11Z","timestamp":1787225291000},"page":"10685-10701","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cloud-based ligand-guided virtual screening with deep-learning-enhanced docking identifies a micromolar CXCR4 antagonist"],"prefix":"10.1007","volume":"30","author":[{"given":"Nonthaneth","family":"Nalinratana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monsin","family":"Sangsawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kian Chee","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junsong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanting","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhai","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Worathat","family":"Thitikornpong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Opa","family":"Vajragupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1391-6993","authenticated-orcid":false,"given":"Pornchai","family":"Rojsitthisak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"11695_CR1","first-page":"02","volume":"1","author":"E Martis","year":"2011","unstructured":"Martis E, Radhakrishnan R, Badve R (2011) High-throughput screening: the hits and leads of drug discovery\u2014an overview. J Appl Pharm Sci 1:02\u201310","journal-title":"J Appl Pharm Sci"},{"key":"11695_CR2","doi-asserted-by":"publisher","first-page":"939","DOI":"10.4155\/fmc-2019-0307","volume":"12","author":"N Berdigaliyev","year":"2020","unstructured":"Berdigaliyev N, Aljofan M (2020) An overview of drug discovery and development. Future Med Chem 12:939\u2013947. https:\/\/doi.org\/10.4155\/fmc-2019-0307","journal-title":"Future Med Chem"},{"key":"11695_CR3","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1007\/s10462-021-10058-4","volume":"55","author":"S Dara","year":"2022","unstructured":"Dara S, Dhamercherla S, Jadav SS, Babu CM, Ahsan MJ (2022) Machine learning in drug discovery: a review. Artif Intell Rev 55:1947\u20131999. https:\/\/doi.org\/10.1007\/s10462-021-10058-4","journal-title":"Artif Intell Rev"},{"key":"11695_CR4","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.cbpa.2007.08.033","volume":"11","author":"C McInnes","year":"2007","unstructured":"McInnes C (2007) Virtual screening strategies in drug discovery. Curr Opin Chem Biol 11:494\u2013502. https:\/\/doi.org\/10.1016\/j.cbpa.2007.08.033","journal-title":"Curr Opin Chem Biol"},{"key":"11695_CR5","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.3390\/ijms20112783","volume":"20","author":"M Batool","year":"2019","unstructured":"Batool M, Ahmad B, Choi S (2019) A structure-based drug discovery paradigm. Int J Mol Sci 20:2783. https:\/\/doi.org\/10.3390\/ijms20112783","journal-title":"Int J Mol Sci"},{"key":"11695_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2020.00343","volume":"8","author":"EHB Maia","year":"2020","unstructured":"Maia EHB, Assis LC, De Oliveira TA, Da Silva AM, Taranto AG (2020) Structure-based virtual screening: from classical to artificial intelligence. Front Chem 8:343. https:\/\/doi.org\/10.3389\/fchem.2020.00343","journal-title":"Front Chem"},{"key":"11695_CR7","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s12539-019-00327-w","volume":"11","author":"J Li","year":"2019","unstructured":"Li J, Fu A, Zhang L (2019) An overview of scoring functions used for protein\u2013ligand interactions in molecular docking. Interdiscip Sci Comput Life Sci 11:320\u2013328. https:\/\/doi.org\/10.1007\/s12539-019-00327-w","journal-title":"Interdiscip Sci Comput Life Sci"},{"key":"11695_CR8","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1021\/acs.jcim.0c00411","volume":"60","author":"PG Francoeur","year":"2020","unstructured":"Francoeur PG, Masuda T, Sunseri J, Jia A, Iovanisci RB, Snyder I, Koes DR (2020) Three-dimensional convolutional neural networks and a cross-docked data set for structure-based drug design. J Chem Inf Model 60:4200\u20134215. https:\/\/doi.org\/10.1021\/acs.jcim.0c00411","journal-title":"J Chem Inf Model"},{"key":"11695_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s13321-021-00522-2","volume":"13","author":"AT McNutt","year":"2021","unstructured":"McNutt AT, Francoeur P, Aggarwal R, Masuda T, Meli R, Ragoza M et al (2021) Gnina 1.0: molecular docking with deep learning. J Cheminform 13:43. https:\/\/doi.org\/10.1186\/s13321-021-00522-2","journal-title":"J Cheminform"},{"key":"11695_CR10","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/978-3-030-16272-6_9","volume-title":"High-performance modelling and simulation for big data applications","author":"A Ol\u011fa\u00e7","year":"2019","unstructured":"Ol\u011fa\u00e7 A, T\u00fcre A, Ol\u011fa\u00e7 S, M\u00f6ller S (2019) Cloud-based high throughput virtual screening in novel drug discovery. In: Kolodziej J, De Meer H (eds) High-performance modelling and simulation for big data applications. Springer, Cham, pp 250\u2013278. https:\/\/doi.org\/10.1007\/978-3-030-16272-6_9"},{"key":"11695_CR11","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1080\/17460441.2021.1932812","volume":"16","author":"O Spjuth","year":"2021","unstructured":"Spjuth O, Frid J, Hellander A (2021) The machine learning life cycle and the cloud: implications for drug discovery. Expert Opin Drug Discov 16:1071\u20131079. https:\/\/doi.org\/10.1080\/17460441.2021.1932812","journal-title":"Expert Opin Drug Discov"},{"key":"11695_CR12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.7150\/thno.5376","volume":"3","author":"B Debnath","year":"2013","unstructured":"Debnath B, Xu S, Grande F, Garofalo A, Neamati N (2013) Small molecule inhibitors of CXCR4. Theranostics 3:47\u201375. https:\/\/doi.org\/10.7150\/thno.5376","journal-title":"Theranostics"},{"key":"11695_CR13","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1126\/science.1194396","volume":"330","author":"B Wu","year":"2010","unstructured":"Wu B, Chien EY, Mol CD, Fenalti G, Liu W, Katritch V et al (2010) Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science 330:1066\u20131071. https:\/\/doi.org\/10.1126\/science.1194396","journal-title":"Science"},{"key":"11695_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00276","volume":"6","author":"E De Clercq","year":"2015","unstructured":"De Clercq E (2015) AMD3100\/CXCR4 inhibitor. Front Immunol 6:276. https:\/\/doi.org\/10.3389\/fimmu.2015.00276","journal-title":"Front Immunol"},{"key":"11695_CR15","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s40265-024-02063-y","volume":"84","author":"SM Hoy","year":"2024","unstructured":"Hoy SM (2024) Mavorixafor: first approval. Drugs 84:969\u2013975. https:\/\/doi.org\/10.1007\/s40265-024-02063-y","journal-title":"Drugs"},{"key":"11695_CR16","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1007\/s40265-023-01962-w","volume":"83","author":"SM Hoy","year":"2023","unstructured":"Hoy SM (2023) Motixafortide: first approval. Drugs 83:1635\u20131643. https:\/\/doi.org\/10.1007\/s40265-023-01962-w","journal-title":"Drugs"},{"key":"11695_CR17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1080\/13543776.2020.1707186","volume":"30","author":"YA Tahirovic","year":"2020","unstructured":"Tahirovic YA, Pelly S, Jecs E, Miller EJ, Sharma SK, Liotta DC, Wilson LJ (2020) Small molecule and peptide-based CXCR4 modulators as therapeutic agents: a patent review for the period from 2010 to 2018. Expert Opin Ther Pat 30:87\u2013101. https:\/\/doi.org\/10.1080\/13543776.2020.1707186","journal-title":"Expert Opin Ther Pat"},{"key":"11695_CR18","doi-asserted-by":"publisher","first-page":"5517","DOI":"10.1073\/pnas.1120431109","volume":"109","author":"MM Mysinger","year":"2012","unstructured":"Mysinger MM, Weiss DR, Ziarek JJ, Gravel S, Doak AK, Karpiak J et al (2012) Structure-based ligand discovery for the protein\u2013protein interface of chemokine receptor CXCR4. Proc Natl Acad Sci USA 109:5517\u20135522. https:\/\/doi.org\/10.1073\/pnas.1120431109","journal-title":"Proc Natl Acad Sci USA"},{"key":"11695_CR19","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jmgm.2012.06.010","volume":"38","author":"JM Planesas","year":"2012","unstructured":"Planesas JM, P\u00e9rez-Nueno VI, Borrell JI, Teixid\u00f3 J (2012) Impact of the CXCR4 structure on docking-based virtual screening of HIV entry inhibitors. J Mol Graph Model 38:123\u2013136. https:\/\/doi.org\/10.1016\/j.jmgm.2012.06.010","journal-title":"J Mol Graph Model"},{"key":"11695_CR20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2425795122","volume":"122","author":"X Sang","year":"2025","unstructured":"Sang X, Jiao H, Meng Q, Fang X, Pan Q, Zhou J et al (2025) Structural mechanisms underlying the modulation of CXCR4 by diverse small-molecule antagonists. Proc Natl Acad Sci USA 122:e2425795122. https:\/\/doi.org\/10.1073\/pnas.2425795122","journal-title":"Proc Natl Acad Sci USA"},{"key":"11695_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24162928","volume":"24","author":"S Zhu","year":"2019","unstructured":"Zhu S, Meng Q, Schooley RT, An J, Xu Y, Huang Z (2019) Structural and biological characterizations of novel high-affinity fluorescent probes with overlapped and distinctive binding regions on CXCR4. Molecules 24:2928. https:\/\/doi.org\/10.3390\/molecules24162928","journal-title":"Molecules"},{"key":"11695_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717. https:\/\/doi.org\/10.1038\/srep42717","journal-title":"Sci Rep"},{"key":"11695_CR23","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30:2785\u20132791. https:\/\/doi.org\/10.1002\/jcc.21256","journal-title":"J Comput Chem"},{"key":"11695_CR24","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1021\/jm901137j","volume":"53","author":"JB Baell","year":"2010","unstructured":"Baell JB, Holloway GA (2010) New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J Med Chem 53:2719\u20132740. https:\/\/doi.org\/10.1021\/jm901137j","journal-title":"J Med Chem"},{"key":"11695_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2025.130027","volume":"115","author":"MM Le Roy","year":"2025","unstructured":"Le Roy MM, M\u00e9tivier C, Rbah-Vidal L, Le Sa\u00ebc P, Bouhsine H, Ch\u00e9rel M et al (2025) Grafting a chromophore on AMD070 analogues for CXCR4 bioimaging: chemical synthesis and in vitro assessment of the inhibition properties of the CXCR4 receptor. Bioorg Med Chem Lett 115:130027. https:\/\/doi.org\/10.1016\/j.bmcl.2025.130027","journal-title":"Bioorg Med Chem Lett"},{"key":"11695_CR26","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1021\/ci9803381","volume":"39","author":"D Butina","year":"1999","unstructured":"Butina D (1999) Unsupervised data base clustering based on Daylight\u2019s fingerprint and Tanimoto similarity: a fast and automated way to cluster small and large data sets. J Chem Inf Comput Sci 39:747\u2013750. https:\/\/doi.org\/10.1021\/ci9803381","journal-title":"J Chem Inf Comput Sci"},{"key":"11695_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fbinf.2025.1695353","volume":"5","author":"G Schottlender","year":"2025","unstructured":"Schottlender G, Prieto JM, Marti MA, Fern\u00e1ndez Do Porto D (2025) Beyond Tanimoto: a learned bioactivity similarity index enhances ligand discovery. Front Bioinform 5:1695353. https:\/\/doi.org\/10.3389\/fbinf.2025.1695353","journal-title":"Front Bioinform"},{"key":"11695_CR28","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1021\/ci990316u","volume":"40","author":"JW Godden","year":"2000","unstructured":"Godden JW, Xue L, Bajorath J (2000) Combinatorial preferences affect molecular similarity\/diversity calculations using binary fingerprints and Tanimoto coefficients. J Chem Inf Comput Sci 40:163\u2013166. https:\/\/doi.org\/10.1021\/ci990316u","journal-title":"J Chem Inf Comput Sci"},{"key":"11695_CR29","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.8357.2","volume":"5","author":"S Jasial","year":"2016","unstructured":"Jasial S, Hu Y, Vogt M, Bajorath J (2016) Activity-relevant similarity values for fingerprints and implications for similarity searching. F1000Res 5:591. https:\/\/doi.org\/10.12688\/f1000research.8357.2","journal-title":"F1000Res"},{"key":"11695_CR30","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1080\/17568919.2024.2389773","volume":"16","author":"V-T To","year":"2024","unstructured":"To V-T, Phan T-L, Doan B-VN, Van Nguyen P-C, Le Q-HN, Nguyen H-H et al (2024) Innovative virtual screening of PD-L1 inhibitors: the synergy of molecular similarity, neural networks and Gnina docking. Future Med Chem 16:2107\u20132118. https:\/\/doi.org\/10.1080\/17568919.2024.2389773","journal-title":"Future Med Chem"},{"key":"11695_CR31","doi-asserted-by":"publisher","first-page":"47051","DOI":"10.1039\/D5RA05526A","volume":"15","author":"A Tripathi","year":"2025","unstructured":"Tripathi A, Suri K, Murugan NA (2025) Assessing the accuracy of binding pose prediction for kinase proteins and 7-azaindole inhibitors: a study with AutoDock4, Vina, DOCK 6, and Gnina 1.0. RSC Adv 15:47051\u201347065. https:\/\/doi.org\/10.1039\/D5RA05526A","journal-title":"RSC Adv"},{"key":"11695_CR32","doi-asserted-by":"publisher","first-page":"9388","DOI":"10.1021\/acs.jcim.4c01429","volume":"64","author":"I Dunn","year":"2024","unstructured":"Dunn I, Pirhadi S, Wang Y, Ravindran S, Concepcion C, Koes DR (2024) Cache challenge #1: docking with Gnina is all you need. J Chem Inf Model 64:9388\u20139396. https:\/\/doi.org\/10.1021\/acs.jcim.4c01429","journal-title":"J Chem Inf Model"},{"key":"11695_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/molecules30163361","volume":"30","author":"R Buccheri","year":"2025","unstructured":"Buccheri R, Rescifina A (2025) High-throughput, high-quality: benchmarking Gnina and AutoDock VINA for precision virtual screening workflow. Molecules 30:3361. https:\/\/doi.org\/10.3390\/molecules30163361","journal-title":"Molecules"},{"key":"11695_CR34","doi-asserted-by":"publisher","first-page":"3743","DOI":"10.1002\/(SICI)1521-3773(19991216)38:24<3743::AID-ANIE3743>3.0.CO;2-U","volume":"38","author":"SJ Teague","year":"1999","unstructured":"Teague SJ, Davis AM, Leeson PD, Oprea T (1999) The design of leadlike combinatorial libraries. Angew Chem Int Ed 38:3743\u20133748. https:\/\/doi.org\/10.1002\/(SICI)1521-3773(19991216)38:24%3c3743::AID-ANIE3743%3e3.0.CO;2-U","journal-title":"Angew Chem Int Ed"},{"key":"11695_CR35","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/cmdc.200700139","volume":"3","author":"R Brenk","year":"2008","unstructured":"Brenk R, Schipani A, James D, Krasowski A, Gilbert IH, Frearson J, Wyatt PG (2008) Lessons learnt from assembling screening libraries for drug discovery for neglected diseases. ChemMedChem 3:435\u2013444. https:\/\/doi.org\/10.1002\/cmdc.200700139","journal-title":"ChemMedChem"},{"key":"11695_CR36","doi-asserted-by":"publisher","first-page":"12006","DOI":"10.1021\/acs.jcim.5c02029","volume":"65","author":"Y Ma","year":"2025","unstructured":"Ma Y, Chen X (2025) Deep-learning vs physics-based docking tools for future coronavirus pandemics. J Chem Inf Model 65:12006\u201312013. https:\/\/doi.org\/10.1021\/acs.jcim.5c02029","journal-title":"J Chem Inf Model"},{"key":"11695_CR37","doi-asserted-by":"publisher","first-page":"9641","DOI":"10.1021\/acs.jmedchem.7b01062","volume":"60","author":"S Di Maro","year":"2017","unstructured":"Di Maro S, Di Leva FS, Trotta AM, Brancaccio D, Portella L, Aurilio M et al (2017) Structure\u2013activity relationships and biological characterization of a novel, potent, and serum stable CXC chemokine receptor type 4 (CXCR4) antagonist. J Med Chem 60:9641\u20139652. https:\/\/doi.org\/10.1021\/acs.jmedchem.7b01062","journal-title":"J Med Chem"},{"key":"11695_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/molecules30061380","volume":"30","author":"G Smaldone","year":"2025","unstructured":"Smaldone G, Di Matteo F, Castelluccio R, Napolitano V, Miranda MR, Manfra M et al (2025) Targeting the CXCR4\/CXCL12 axis in cancer therapy: analysis of recent advances in the development of potential anticancer agents. Molecules 30:1380. https:\/\/doi.org\/10.3390\/molecules30061380","journal-title":"Molecules"},{"key":"11695_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-73012-4","volume":"10","author":"M Harms","year":"2020","unstructured":"Harms M, Gilg A, St\u00e4ndker L, Beer AJ, Mayer B, Rasche V et al (2020) Microtiter plate-based antibody-competition assay to determine binding affinities and plasma\/blood stability of CXCR4 ligands. Sci Rep 10:16036. https:\/\/doi.org\/10.1038\/s41598-020-73012-4","journal-title":"Sci Rep"},{"key":"11695_CR40","doi-asserted-by":"publisher","unstructured":"Khan A, Silversides JD, Madden L, Greenman J, Archibald SJ (2007) Fluorescent CXCR4 chemokine receptor antagonists: metal activated binding. Chem Commun 416\u2013418. https:\/\/doi.org\/10.1039\/b614557d","DOI":"10.1039\/b614557d"},{"key":"11695_CR41","doi-asserted-by":"publisher","first-page":"6560","DOI":"10.1021\/jm301916b","volume":"56","author":"T Zhu","year":"2013","unstructured":"Zhu T, Cao S, Su P-C, Patel R, Shah D, Chokshi HB et al (2013) Hit identification and optimization in virtual screening: practical recommendations based on a critical literature analysis. J Med Chem 56:6560\u20136572. https:\/\/doi.org\/10.1021\/jm301916b","journal-title":"J Med Chem"},{"key":"11695_CR42","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1634\/stemcells.2005-0085","volume":"23","author":"Y Guo","year":"2005","unstructured":"Guo Y, Hangoc G, Bian H, Pelus LM, Broxmeyer HE (2005) SDF-1\/CXCL12 enhances survival and chemotaxis of murine embryonic stem cells and production of primitive and definitive hematopoietic progenitor cells. Stem Cells 23:1324\u20131332. https:\/\/doi.org\/10.1634\/stemcells.2005-0085","journal-title":"Stem Cells"},{"key":"11695_CR43","doi-asserted-by":"publisher","first-page":"G1059","DOI":"10.1152\/ajpgi.00417.2003","volume":"286","author":"J Heidemann","year":"2004","unstructured":"Heidemann J, Ogawa H, Rafiee P, L\u00fcgering N, Maaser C, Domschke W et al (2004) Mucosal angiogenesis regulation by CXCR4 and its ligand CXCL12 expressed by human intestinal microvascular endothelial cells. Am J Physiol Gastrointest Liver Physiol 286:G1059\u2013G1068. https:\/\/doi.org\/10.1152\/ajpgi.00417.2003","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"11695_CR44","doi-asserted-by":"publisher","unstructured":"Van Hout A, D'huys T, Oeyen M, Schols D, Van Loy T (2017) Comparison of cell-based assays for the identification and evaluation of competitive CXCR4 inhibitors. PLoS ONE 12:e0176057. https:\/\/doi.org\/10.1371\/journal.pone.0176057","DOI":"10.1371\/journal.pone.0176057"},{"key":"11695_CR45","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/ijc.27670","volume":"132","author":"T Murakami","year":"2013","unstructured":"Murakami T, Kawada K, Iwamoto M, Akagami M, Hida K, Nakanishi Y et al (2013) The role of CXCR3 and CXCR4 in colorectal cancer metastasis. Int J Cancer 132:276\u2013287. https:\/\/doi.org\/10.1002\/ijc.27670","journal-title":"Int J Cancer"},{"key":"11695_CR46","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/01.sla.0000217690.65909.9c","volume":"244","author":"J Kim","year":"2006","unstructured":"Kim J, Mori T, Chen SL, Amersi FF, Martinez SR, Kuo C et al (2006) Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome. Ann Surg 244:113\u2013120. https:\/\/doi.org\/10.1097\/01.sla.0000217690.65909.9c","journal-title":"Ann Surg"},{"key":"11695_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13133284","volume":"13","author":"A Ottaiano","year":"2021","unstructured":"Ottaiano A, Santorsola M, Del Prete P, Perri F, Scala S, Caraglia M, Nasti G (2021) Prognostic significance of CXCR4 in colorectal cancer: an updated meta-analysis and critical appraisal. Cancers 13:3284. https:\/\/doi.org\/10.3390\/cancers13133284","journal-title":"Cancers"},{"key":"11695_CR48","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.4103\/0366-6999.191782","volume":"129","author":"B-Y Xie","year":"2016","unstructured":"Xie B-Y, Wu A-W (2016) Organoid culture of isolated cells from patient-derived tissues with colorectal cancer. Chin Med J 129:2469\u20132475. https:\/\/doi.org\/10.4103\/0366-6999.191782","journal-title":"Chin Med J"},{"key":"11695_CR49","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s11888-016-0335-4","volume":"12","author":"M Young","year":"2016","unstructured":"Young M, Reed KR (2016) Organoids as a model for colorectal cancer. Curr Colorectal Cancer Rep 12:281\u2013287. https:\/\/doi.org\/10.1007\/s11888-016-0335-4","journal-title":"Curr Colorectal Cancer Rep"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11695-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11695-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11695-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:03:58Z","timestamp":1793858638000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11695-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":49,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["11695"],"URL":"https:\/\/doi.org\/10.1007\/s11030-026-11695-z","relation":{},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"assertion":[{"value":"12 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Kian Chee Chong is affiliated with QDX Co. Ltd., which developed and operates the Rush cloud platform (rush.cloud) used in this study. The platform was accessed through a commercial service agreement between the Center of Excellence in Natural Products for Ageing and Chronic Diseases, Chulalongkorn University, and QDX. All other authors declare no competing financial interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}